Chad M Cohen Insider Trading $ADPT Adaptive Biotechnologies Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Chad M Cohen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Chad M Cohen. Chad M Cohen is CFO & Treasurer in ZILLOW INC ($Z) and Director in TRUPANION INC. ($TRUP) and Chief Financial Officer in Adaptive Biotechnologies Corp ($ADPT).
Chad M Cohen in Adaptive Biotechnologies Corp
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Chad M Cohen: Chief Financial Officer
Holdings: 31,604 shares
Latest Transaction: May 13 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Chad M Cohen in Adaptive Biotechnologies Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.55 | 10,000 | 65,500 | 130,000 | |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.55 | 10,000 | 65,500 | 140,000 | |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 32.63 | 10,000 | 326,300 | 21,604 | 31.6 K to 21.6 K (-31.64 %) |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.55 | 10,000 | 65,500 | 31,604 | 21.6 K to 31.6 K (+46.29 %) |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 31.84 | 7,031 | 223,867 | 21,604 | 28.6 K to 21.6 K (-24.55 %) |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 30.81 | 2,969 | 91,475 | 28,635 | 31.6 K to 28.6 K (-9.39 %) |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.55 | 10,000 | 65,500 | 31,604 | 21.6 K to 31.6 K (+46.29 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 10,000 | 63,200 | 25,000 | |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 10,000 | 63,200 | 35,000 | |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 42.34 | 806 | 34,126 | 21,604 | 22.4 K to 21.6 K (-3.60 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 41.59 | 9,194 | 382,378 | 22,410 | 31.6 K to 22.4 K (-29.09 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 10,000 | 63,200 | 31,604 | 21.6 K to 31.6 K (+46.29 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.95 | 10,000 | 409,500 | 21,604 | 31.6 K to 21.6 K (-31.64 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 10,000 | 63,200 | 31,604 | 21.6 K to 31.6 K (+46.29 %) |
| Mar 12 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 10,000 | 63,200 | 45,000 | |
| Mar 12 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 42.54 | 10,000 | 425,400 | 21,604 | 31.6 K to 21.6 K (-31.64 %) |
| Mar 12 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 10,000 | 63,200 | 31,604 | 21.6 K to 31.6 K (+46.29 %) |
| Mar 10 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 10,000 | 63,200 | 55,000 | |
| Mar 10 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.79 | 2,890 | 117,883 | 21,064 | 24 K to 21.1 K (-12.06 %) |
| Mar 10 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.02 | 7,110 | 284,542 | 23,954 | 31.1 K to 24 K (-22.89 %) |
| Mar 10 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 10,000 | 63,200 | 31,064 | 21.1 K to 31.1 K (+47.47 %) |
| Mar 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | A | 43.68 | 51,511 | 2,250,000 | 51,511 | |
| Mar 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Grant | A | 0.00 | 20,604 | 0 | 21,604 | 1,000 to 21.6 K (+2,060.40 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 65,000 | |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 115,000 | |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 57.70 | 2,184 | 126,017 | 1,000 | 3.2 K to 1,000 (-68.59 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 56.68 | 9,704 | 550,023 | 3,184 | 12.9 K to 3.2 K (-75.29 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 55.77 | 38,112 | 2,125,506 | 12,888 | 51 K to 12.9 K (-74.73 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 57.00 | 18,523 | 1,055,811 | 1,000 | 19.5 K to 1,000 (-94.88 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 56.00 | 23,698 | 1,327,088 | 19,523 | 43.2 K to 19.5 K (-54.83 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 55.04 | 7,779 | 428,156 | 43,221 | 51 K to 43.2 K (-15.25 %) |
| Feb 01 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 165,000 | |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 215,000 | |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 65.47 | 5,920 | 387,582 | 1,000 | 6.9 K to 1,000 (-85.55 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 64.54 | 20,785 | 1,341,464 | 6,920 | 27.7 K to 6.9 K (-75.02 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 63.65 | 12,977 | 825,986 | 27,705 | 40.7 K to 27.7 K (-31.90 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 62.71 | 10,318 | 647,042 | 40,682 | 51 K to 40.7 K (-20.23 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 67.68 | 1,000 | 67,680 | 1,000 | 2 K to 1,000 (-50.00 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 67.03 | 17,436 | 1,168,735 | 2,000 | 19.4 K to 2 K (-89.71 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 65.69 | 20,953 | 1,376,403 | 19,436 | 40.4 K to 19.4 K (-51.88 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 65.08 | 10,611 | 690,564 | 40,389 | 51 K to 40.4 K (-20.81 %) |
| Jan 27 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 265,000 | |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 68.33 | 5,012 | 342,470 | 1,000 | 6 K to 1,000 (-83.37 %) |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 67.35 | 33,938 | 2,285,724 | 6,012 | 40 K to 6 K (-84.95 %) |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 66.82 | 11,050 | 738,361 | 39,950 | 51 K to 40 K (-21.67 %) |
| Jan 22 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 315,000 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 70.66 | 6,889 | 486,777 | 1,000 | 7.9 K to 1,000 (-87.32 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 69.74 | 14,201 | 990,378 | 7,889 | 22.1 K to 7.9 K (-64.29 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 69.00 | 6,695 | 461,955 | 22,090 | 28.8 K to 22.1 K (-23.26 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 67.75 | 4,581 | 310,363 | 28,785 | 33.4 K to 28.8 K (-13.73 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 66.97 | 17,634 | 1,180,949 | 33,366 | 51 K to 33.4 K (-34.58 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 365,000 | |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 63.63 | 34,180 | 2,174,873 | 1,000 | 35.2 K to 1,000 (-97.16 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 62.92 | 15,820 | 995,394 | 35,180 | 51 K to 35.2 K (-31.02 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 50,000 | 316,000 | 51,000 | 1,000 to 51 K (+5,000.00 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 75,000 | 474,000 | 415,000 | |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 63.73 | 1,200 | 76,476 | 1,000 | 2.2 K to 1,000 (-54.55 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 62.96 | 33,827 | 2,129,748 | 2,200 | 36 K to 2.2 K (-93.89 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 62.25 | 39,973 | 2,488,319 | 36,027 | 76 K to 36 K (-52.60 %) |
| Jan 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 75,000 | 474,000 | 76,000 | 1,000 to 76 K (+7,500.00 %) |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 30,000 | 189,600 | 490,000 | |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 52.38 | 300 | 15,714 | 1,000 | 1.3 K to 1,000 (-23.08 %) |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 51.98 | 9,444 | 490,899 | 1,300 | 10.7 K to 1.3 K (-87.90 %) |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 50.88 | 20,256 | 1,030,625 | 10,744 | 31 K to 10.7 K (-65.34 %) |
| Dec 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 30,000 | 189,600 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
| Nov 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 30,000 | 189,600 | 520,000 | |
| Nov 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 50.92 | 1,760 | 89,619 | 1,000 | 2.8 K to 1,000 (-63.77 %) |
| Nov 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 49.63 | 11,089 | 550,347 | 2,760 | 13.8 K to 2.8 K (-80.07 %) |
| Nov 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 48.67 | 17,151 | 834,739 | 13,849 | 31 K to 13.8 K (-55.33 %) |
| Nov 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 30,000 | 189,600 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 8,588 | 54,276 | 580,000 | |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 1,412 | 8,924 | 588,588 | |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.00 | 8,588 | 343,520 | 1,000 | 9.6 K to 1,000 (-89.57 %) |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 8,588 | 54,276 | 9,588 | 1,000 to 9.6 K (+858.80 %) |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.00 | 1,412 | 56,480 | 1,000 | 2.4 K to 1,000 (-58.54 %) |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 8,588 | 54,276 | 580,000 | |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 1,412 | 8,924 | 2,412 | 1,000 to 2.4 K (+141.20 %) |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 1,412 | 8,924 | 588,588 | |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.00 | 8,588 | 343,520 | 1,000 | 9.6 K to 1,000 (-89.57 %) |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 8,588 | 54,276 | 9,588 | 1,000 to 9.6 K (+858.80 %) |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.00 | 1,412 | 56,480 | 1,000 | 2.4 K to 1,000 (-58.54 %) |
| Sep 11 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 1,412 | 8,924 | 2,412 | 1,000 to 2.4 K (+141.20 %) |
| Sep 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 20,000 | 126,400 | 590,000 | |
| Sep 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 36.17 | 20,000 | 723,400 | 1,000 | 21 K to 1,000 (-95.24 %) |
| Sep 09 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 20,000 | 126,400 | 21,000 | 1,000 to 21 K (+2,000.00 %) |
| Aug 19 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 10,000 | 63,200 | 610,000 | |
| Aug 19 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.00 | 10,000 | 400,000 | 1,000 | 11 K to 1,000 (-90.91 %) |
| Aug 19 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 10,000 | 63,200 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 20,000 | 126,400 | 620,000 | |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 37.78 | 20,000 | 755,600 | 1,000 | 21 K to 1,000 (-95.24 %) |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 20,000 | 126,400 | 21,000 | 1,000 to 21 K (+2,000.00 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 30,000 | 189,600 | 640,000 | |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 47.52 | 2,104 | 99,982 | 1,000 | 3.1 K to 1,000 (-67.78 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 46.82 | 27,896 | 1,306,091 | 3,104 | 31 K to 3.1 K (-89.99 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 30,000 | 189,600 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 30,000 | 189,600 | 640,000 | |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 47.52 | 2,104 | 99,982 | 1,000 | 3.1 K to 1,000 (-67.78 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 46.82 | 27,896 | 1,306,091 | 3,104 | 31 K to 3.1 K (-89.99 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 30,000 | 189,600 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
| Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 8,750 | 55,300 | 670,000 | |
| Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 21,250 | 134,300 | 678,750 | |
| Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.00 | 8,750 | 350,000 | 1,000 | 9.8 K to 1,000 (-89.74 %) |
| Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 8,750 | 55,300 | 9,750 | 1,000 to 9.8 K (+875.00 %) |
| Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 39.80 | 2,445 | 97,311 | 1,000 | 3.4 K to 1,000 (-70.97 %) |
| Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 38.99 | 18,805 | 733,207 | 3,445 | 22.3 K to 3.4 K (-84.52 %) |
| Jun 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 21,250 | 134,300 | 22,250 | 1,000 to 22.3 K (+2,125.00 %) |
| May 21 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 4.07 | 30,000 | 122,100 | 0 | |
| May 21 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 20,000 | 126,400 | 700,000 | |
| May 21 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.00 | 50,000 | 2,000,000 | 1,000 | 51 K to 1,000 (-98.04 %) |
| May 21 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 20,000 | 126,400 | 51,000 | 31 K to 51 K (+64.52 %) |
| May 21 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 4.07 | 30,000 | 122,100 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
| May 21 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 4.07 | 30,000 | 122,100 | 0 | |
| May 21 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 20,000 | 126,400 | 700,000 | |
| May 21 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.00 | 50,000 | 2,000,000 | 1,000 | 51 K to 1,000 (-98.04 %) |
| May 21 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 20,000 | 126,400 | 51,000 | 31 K to 51 K (+64.52 %) |
| May 21 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 4.07 | 30,000 | 122,100 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
| May 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 20,000 | 126,400 | 720,000 | |
| May 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 35.92 | 20,000 | 718,400 | 1,000 | 21 K to 1,000 (-95.24 %) |
| May 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 20,000 | 126,400 | 21,000 | 1,000 to 21 K (+2,000.00 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 4.07 | 10,000 | 40,700 | 20,000 | |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 30.00 | 10,000 | 300,000 | 1,000 | 11 K to 1,000 (-90.91 %) |
| Apr 22 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 4.07 | 10,000 | 40,700 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
| Apr 08 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 4.07 | 15,000 | 61,050 | 30,000 | |
| Apr 08 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 25.07 | 5,300 | 132,871 | 1,000 | 6.3 K to 1,000 (-84.13 %) |
| Apr 08 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 24.14 | 9,700 | 234,158 | 6,300 | 16 K to 6.3 K (-60.62 %) |
| Apr 08 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 4.07 | 15,000 | 61,050 | 16,000 | 1,000 to 16 K (+1,500.00 %) |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | A | 31.71 | 85,000 | 2,695,350 | 85,000 | |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 4.07 | 20,000 | 81,400 | 60,000 | |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 31.44 | 16,721 | 525,708 | 1,000 | 17.7 K to 1,000 (-94.36 %) |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 31.90 | 3,279 | 104,600 | 17,721 | 21 K to 17.7 K (-15.61 %) |
| Feb 12 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 4.07 | 20,000 | 81,400 | 21,000 | 1,000 to 21 K (+2,000.00 %) |
| Jan 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 4.07 | 20,000 | 81,400 | 80,000 | |
| Jan 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 29.87 | 20,000 | 597,400 | 1,000 | 21 K to 1,000 (-95.24 %) |
| Jan 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 4.07 | 20,000 | 81,400 | 21,000 | 1,000 to 21 K (+2,000.00 %) |
| Jul 03 2019 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | P | 20.00 | 1,000 | 20,000 | 1,000 | 0 to 1,000 |
Page: 1